Tokyo Tape
Sign in
← Japan Tobacco

Half-year report · Q2

2914.TEDINET S100WZBM
Period2025-01-01 → 2025-06-30
Filed2025-11-06
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed

Amends S100WFZ4. Amended by S100WZC4 (2025-11-06).

Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.73T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥3.15T2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.57T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income¥479.9bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥432.7bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax¥437.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥233.8bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥399.1bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥319.9bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥179.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥305.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥322.0bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income¥182.6bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥307.1bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥8.26Tat 2025-06-30Cons.Assets IFRS
Total assets¥8.37Tat 2024-12-31Cons.Assets IFRS
Total assets¥7.87Tat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥4.12Tat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥4.52Tat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥4.14Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥3.85Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥4.53Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥4.06Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.77Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥865.2bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.08Tat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.09Tat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥167.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥630.0bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥260.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥132.0bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥439.8bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥28.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥230.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥94.9bn2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥267.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥180.192025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥100.952024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥171.892024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥180.172025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥100.942024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥171.862024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.1%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.0%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio56.4%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥686m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.9bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥1.9bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥1.9bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥48.3bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥48.3bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.2bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.2bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30−¥20.2bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue2025-01-01 → 2025-06-30¥76.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue external2025-01-01 → 2025-06-30¥76.7bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥14m
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.6bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.6bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥3.0bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue2025-01-01 → 2025-06-30¥1.61T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue external2025-01-01 → 2025-06-30¥1.61T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥0
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥556.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥556.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥520.9bn
—segment totalrevenue2025-01-01 → 2025-06-30¥1.73T
—segment totalrevenue external2025-01-01 → 2025-06-30¥1.73T
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥14m
—segment totalsegment profit2025-01-01 → 2025-06-30¥562.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥562.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥503.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥658m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥27.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥27.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥25.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥44.1bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥44.1bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-06-30¥73.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-06-30¥73.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥13m
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.4bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.4bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.3bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-06-30¥1.45T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-06-30¥1.45T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥182m
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥472.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥472.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥449.6bn
—segment totalrevenue2024-01-01 → 2024-06-30¥1.57T
—segment totalrevenue external2024-01-01 → 2024-06-30¥1.57T
—segment totalrevenue intersegment2024-01-01 → 2024-06-30¥196m
—segment totalsegment profit2024-01-01 → 2024-06-30¥480.5bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥480.5bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥458.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 980
ItemContextValueUnit
Profit loss before tax IFRSPrior1YTDDuration399073000000JPY
Profit loss before tax IFRSCurrentYTDDuration437821000000JPY
Income tax expense IFRSPrior1YTDDuration91946000000JPY
Income tax expense IFRSCurrentYTDDuration115856000000JPY
Profit loss IFRSPrior1YTDDuration307126000000JPY
Profit loss IFRSCurrentYTDDuration321965000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration305172000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration319905000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration1954000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration2060000000JPY
Profit loss IFRSPrior1YTDDuration307126000000JPY
Profit loss IFRSCurrentYTDDuration321965000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration171.89
Basic earnings loss per share IFRSCurrentYTDDuration180.19
Diluted earnings loss per share IFRSPrior1YTDDuration171.86
Diluted earnings loss per share IFRSCurrentYTDDuration180.17
Profit loss IFRSPrior1YTDDuration307126000000JPY
Profit loss IFRSCurrentYTDDuration321965000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration2036000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-85000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration16360000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration185000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration18396000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration100000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration471355000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration150415000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-4839000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-4676000000JPY
Hedge costs net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-122000000JPY
Hedge costs net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-14000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration466395000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration145726000000JPY
Other comprehensive income IFRSPrior1YTDDuration484791000000JPY
Other comprehensive income IFRSCurrentYTDDuration145826000000JPY
Comprehensive income IFRSPrior1YTDDuration791917000000JPY
Comprehensive income IFRSCurrentYTDDuration467791000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration788399000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration466041000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration3519000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration1750000000JPY
Comprehensive income IFRSPrior1YTDDuration791917000000JPY
Comprehensive income IFRSCurrentYTDDuration467791000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember100000000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember736478000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-489194000000JPY
Equity IFRSPrior2YearInstant_ShareAcquisitionRightsIFRSMember557000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember270810000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember9145000000JPY
Equity IFRSPrior2YearInstant_jpcrp040300-q2r_E00492-000HedgeCostsIFRSMember-17000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass